Your browser doesn't support javascript.
loading
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib.
de Velasco, Guillermo; Alonso-Gordoa, Teresa; Rodríguez-Vida, Alejo; Anguera, Georgia; Campayo, Marc; Pinto, Álvaro; Ortega, Esther Martínez; Gallardo, Enrique; Núñez, Natalia Fernández; García-Carbonero, Iciar; Reig, Oscar; Méndez-Vidal, María José; Fernández-Calvo, Ovidio; Cassinello, Natalia Vidal; Torregrosa, Dolores; López-Martín, Ana; Rosero, Adriana; Valiente, Patricia G; de España, Carmen Garcías; Climent, Miguel A; Santasusana, Montserrat Domenech; Sánchez, Ángel Rodríguez; González, Isabel Chirivella; Afonso, Ruth; García Del Muro, Xavier; Casinello, Javier; Fernández-Parra, Eva M; García Sánchez, Lourdes; Afonso, Javier; Polo, Susana Hernando; Asensio, Úrsula.
Afiliação
  • de Velasco G; Department of Medical Oncology, Madrid, Spain. Electronic address: Gdvelasco.gdv@gmail.com.
  • Alonso-Gordoa T; Department of Medical Oncology and Department of Genitourinary, Germ cell and Endocrine Tumors, Ramón y Cajal University Hospital and Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
  • Rodríguez-Vida A; Department of Medical Oncology, Hospital del Mar-CIBERONC, IMIM Research Institute, Barcelona, Spain.
  • Anguera G; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Campayo M; Department of Medical Oncology, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain.
  • Pinto Á; Department of Medical Oncology, University Hospital La Paz, Madrid, Spain.
  • Ortega EM; Department of Medical Oncology, University Hospital of Jaén, Jaén, Spain.
  • Gallardo E; Department of Medical Oncology, University Hospital Parc Taulí, Institut d'Investigació i Innovació Parc Taulí, Sabadell, Spain.
  • Núñez NF; Department of Medical Oncology, University Hospital Lucus Augusti, Lugo, Spain.
  • García-Carbonero I; Department of Medical Oncology, University Hospital of Toledo, Toledo, Spain.
  • Reig O; Department of Medical Oncology, Hospital Clínic and Translational Genomics and Targeted Therapeutics in Solid Tumors Group (IDIBAPS), Barcelona, Spain.
  • Méndez-Vidal MJ; Department of Medical Oncology, University Hospital Reina Sofía, Maimónides Institute for Biomedical research of Córdoba (IMIBIC), Córdoba, Spain.
  • Fernández-Calvo O; Department of Medical Oncology, University Hospital of Ourense, Ourense, Spain.
  • Cassinello NV; Department of Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.
  • Torregrosa D; Department of Medical Oncology, University Hospital Dr. Peset, Valencia, Spain.
  • López-Martín A; Medical Oncology Department, University Hospital Severo Ochoa, Madrid, Spain.
  • Rosero A; Department of Medical Oncology, University Hospital Infanta Cristina, Parla, Madrid, Spain.
  • Valiente PG; Department of Medical Oncology, University Hospital Marqués de Valdecilla, Santander, Spain.
  • de España CG; Department of Medical Oncology, University Hospital Son Espases, Palma de Mallorca, Spain.
  • Climent MA; Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Santasusana MD; Department of Medical Oncology, Hospital Althaia, Manresa, Spain.
  • Sánchez ÁR; Department of Medical Oncology, University Hospital of León, León, Spain.
  • González IC; Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA, University of Valencia, Valencia, Spain.
  • Afonso R; Department of Medical Oncology, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
  • García Del Muro X; Genitourinary Cancer and Sarcoma Unit, Institut Català d'Oncologia, Hospitalet, Barcelona, Spain.
  • Casinello J; Department of Medical Oncology, University Hospital of Guadalajara, Guadalajara, Spain.
  • Fernández-Parra EM; Department of Medical Oncology, University Hospital Valme, Sevilla, Spain.
  • García Sánchez L; Department of Medical Oncology, University Hospital of Segovia, Segovia, Spain.
  • Afonso J; Department of Medical Oncology, University Hospital of Ferrol, A Coruña, Spain.
  • Polo SH; Department of Medical Oncology, University Hospital Fundación Alcorcón, Madrid, Spain.
  • Asensio Ú; Medical Department, Pfizer Oncology, Madrid, Spain.
Clin Genitourin Cancer ; 21(3): e166-e174, 2023 06.
Article em En | MEDLINE | ID: mdl-36610891
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Clin Genitourin Cancer Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Revista: Clin Genitourin Cancer Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2023 Tipo de documento: Article